Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> HCV News and Updates
Post Info TOPIC: HCV News and Updates
Isiscat2011


Guru

Status: Offline
Posts: 1724
Date:
RE: HCV News and Updates
Permalink  
 

Hahaha.........

Another flaw in this study is that it apparently assigns the same value to each of the "negative predictors."  That is to say 1 point for gender, 1 point for cirrhosis, etc., etc.   There is no way that gender and cirrhosis are of equal value in determining treatment outcomes for this combo (or probably any other combo).   

If I was going to rely on statistics to predict outcome, I would be more likely to rely on the clinical trial data, and even those are flawed and have limited predictability value.  



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Would a "caveat emptor" apply here? There is indeed an assumption of average weight in the female gender Isis, it's called, "You look great honey, I wouldn't change a thing..."  >>>>>BIG GRIN<<<<<

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
Isiscat2011


Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

P.S.  I should qualify that statement: the average weight for an AMERICAN male is 180 (height 5'9").

No need to post the average weight of women; we won't EVEN be going there, girlfriend.smile



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.
Isiscat2011


Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

I'm not sure how promising I would interpret this, particularly if I was a male (most men do weigh at least 165 pounds, most do not have the CC allele, and most have VLs > 800K) but don't be discouraged if you have more than 3 of the listed predictors.

First and foremost, these study results are only meaningful if you are on the Interferon/Riba/Sovaldi combo.

Additionally, this study (or at least what is written in the article about this study) considers only efficacy (SVR rates) and an equally important factor in the equation is safety.  Using safer drugs will allow relapsers to more safely retreat with much greater ease if necessary.  Many docs recommend that people on Int/Riba combos don't even try to re-treat for at least 12-18 months after a failed older tx; with safer drugs re-treatment can probably begin much sooner.

Additionally, if you view the study critically you will see it contains many flaws, including but not limited to, the following:

1) It is a relatively small sample and, therefore, not necessarily representative of the results that may be seen in the general public,

2) It fails to distinguish results among the specific genotypes.

 



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.
longld


Senior Member

Status: Offline
Posts: 134
Date:
Permalink  
 

Tig,   copied the negative predictors summary - very promising!

 

Six negative predictors were associated with relapse among all patients:

male sex,

weighing at least 75 kg,

IL-28B non-cc genotype, 

cirrhosis,

baseline hepatitis C virus (HCV) RNA 800,000 IU/mL and

previous treatment failure.

Ninety percent or more in patients in all genotypes still achieved SVR when they had three or fewer negative predictors. SVR rates declined among patients with five or more negative predictors.



-- Edited by longld on Sunday 18th of May 2014 05:54:10 AM

__________________

62 Yrs Old, CHC Geno 3, Cirrhosis, Kidney Transplant (13 yrs), On Sovaldi/Riba Treatment (24 week) since Feb 01,2014

Viral Load 7M on 1/8/2014,  UND at EOT 7/18/2014
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

I get email updates containing random new, sometimes dated, yet occasionally interesting articles. Take a look and see what you think, who knows, you might find the answer to that question that kept you awake all night, or maybe not, but it's all food for thought! 

Tig

PCP training program increased number of patients receiving HCV treatment

Tacrolimus triple therapy reduced fibrosis among cirrhotic HCV patients after liver transplantation

Simeprevir (Olysio): A New NS3/4A Protease Inhibitor

HCV patients treated with sofosbuvir maintained high SVR despite negative predictors

Researchers Identify HCV Surface Protein, Raise Hope for Vaccine

 



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> HCV News and Updates
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.